Aminoglycoside nephrotoxicity: a double blind prospective randomized study of gentamicin and tobramycin.
D000118:Acetylglucosaminidase / Q000652:urine; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D003404:Creatinine / Q000097:blood; D004311:Double-Blind Method; D005260:Female; D005839:Gentamicins / Q000009:adverse effects*; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011897:Random Allocation; D014031:Tobramycin / Q000009:adverse effects*; D001613:beta 2-Microglobulin / Q000652:urine
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D001613:beta 2-Microglobulin; D003404:Creatinine; D000118:Acetylglucosaminidase; D014031:Tobramycin